Literature DB >> 26399978

Role of ERK1/2 and JNK phosphorylation in iodine contrast agent-induced apoptosis in diabetic rat kidneys.

Zhanquan Jiao1, Jun Chen1, Yanhong Liu2, Tong Liu1, Kangyin Chen1, Guangping Li1.   

Abstract

BACKGROUND: The risk of contrast-induced acute kidney injury (CIAKI) is significantly increased in patients with diabetes mellitus. This study aimed to investigate molecular mechanisms of contrast media-induced apoptosis in diabetic rat kidneys, especially the involvement of ERK1/2 and JNK signal pathways.
METHODS: Diabetic Sprague-Dawley rats were induced by intraperitoneal injection of streptozotocin. Ten weeks later the normal and diabetic rats were administered high-osmolar contrast media (HOCM; meglumine diatrizoate) or normal saline (10 mL/kg) injection for 2 consecutive days. At 24 h after the operation, the rats were sacrificed, the blood samples were collected for examining serum creatinine and the kidneys were collected for determining the expression of caspase-3 by immunohistochemistry and the expression of Bcl-2, Bax, upstream signal molecule p-JNK, and p-ERK1/2 by western blotting.
RESULTS: The serum creatinine was significantly increased in diabetes + contrast media group (DC group) after operation compared with in the diabetic group (D group; 103.89 ± 9.01 μmol/L vs. 71.52 ± 7.03 μmol/L, p < 0.05). While creatinine clearance rate (Ccr) was significantly decreased in DC group after operation (1.49 ± 0.33 mL/min vs. 2.60 ± 0.54 mL/min, p < 0.05). Especially, in the diabetic kidney, the expression of caspase-3 was also significantly increased after intravenous injection of HOCM compared with normal saline. The expression level of upstream signal molecule p-JNK protein was apparently increased, but p-ERK1/2 protein was significantly decreased (both p < 0.05).
CONCLUSIONS: The ionic HOCM-induced renal cells apoptosis in diabetic rats through activating the caspase-3 apoptotic pathway, which might be mediated by upstream MAPK (inhibiting p-ERK1/2 expression and promoting p-JNK expression) signal pathways.

Entities:  

Keywords:  Apoptosis; ERK1/2; JNK; contrast-induced acute kidney injury; diabetes mellitus

Mesh:

Substances:

Year:  2015        PMID: 26399978     DOI: 10.3109/0886022X.2015.1068031

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  5 in total

1.  Oxidative stress caused by activation of NADPH oxidase 4 promotes contrast-induced acute kidney injury.

Authors:  Bo Young Jeong; Hoi Young Lee; Chang Gyo Park; Jaeku Kang; Seong-Lan Yu; Du-Ri Choi; Seung-Yun Han; Moon Hyang Park; Sungkwon Cho; Soo Young Lee; Won-Min Hwang; Sung-Ro Yun; Hye-Myung Ryu; Eun-Joo Oh; Sun-Hee Park; Yong-Lim Kim; Se-Hee Yoon
Journal:  PLoS One       Date:  2018-01-12       Impact factor: 3.240

2.  Rapeseed protein-derived antioxidant peptide RAP alleviates renal fibrosis through MAPK/NF-κB signaling pathways in diabetic nephropathy.

Authors:  Mingyan Zhang; Zhibin Yan; Lili Bu; Chunmei An; Dan Wang; Xin Liu; Jianfeng Zhang; Wenle Yang; Bochuan Deng; Junqiu Xie; Bangzhi Zhang
Journal:  Drug Des Devel Ther       Date:  2018-05-15       Impact factor: 4.162

3.  Iso-Osmolar Iodixanol Induces Less Increase in Circulating Endothelial Microparticles In Vivo and Less Endothelial Apoptosis In Vitro Compared with Low-Osmolar Iohexol.

Authors:  Beijian Zhang; Yi Zhang; Bo Liu; Lu Fang; Yigang Li; Shu Meng
Journal:  Contrast Media Mol Imaging       Date:  2018-04-10       Impact factor: 3.161

4.  Probucol Protects Against Contrast-Induced Acute Kidney Injury via the Extracellular Signal-Regulated Kinases 1 and 2 (ERK1/2)/JNK-Caspase 3 Pathway in Diabetic Rats.

Authors:  Xingxing Ma; Zhanquan Jiao; Yanhong Liu; Jun Chen; Guangping Li; Tong Liu; Gary Tse; Ruyu Yuan
Journal:  Med Sci Monit       Date:  2019-02-07

5.  Anti-Apoptotic and Antioxidant Effects of 3-Epi-Iso-Seco-Tanapartholide Isolated from Artemisia Argyi Against Iodixanol-Induced Kidney Epithelial Cell Death.

Authors:  Dahae Lee; Kem Ok Kim; Dongho Lee; Ki Sung Kang
Journal:  Biomolecules       Date:  2020-06-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.